Insight
AI in M&A: 10 Things to Consider in Acquisitions
by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023

by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023
by Harry Clark, Jeanine P. McGuinness and Elizabeth Zane
5 minute read | August.14.2023
by Nicola Whiteley, Emma Zarb, Charlotte Oliver and Heather Hanlon
9 minute read | August.29.2023
by Richard F. Martinelli and Daniel Patrick Kearney
4 minute read | August.03.2023
by Annette Hurst, Daniel Yost, Ramin Tohidi, Sarah Schaedler and Daniel Healow
10 minute read | August.03.2023
by Dr. Daniel Ashkar
2 minute read | September.01.2023
Instructive overview of material GDPR requirements in relation to AI applications as well as related practical guidance (German language article)
by Robert Loeb, Cesar Lopez-Morales, Ed Williams and Ramon J. Ryan
4 minute read | February.07.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.
4 minute read | January.23.2025
by Thora Johnson, Alyssa Wolfington and Michaela Frai
6 minute read | January.27.2025
by Harry Clark, Elizabeth Zane, Gregory I. Hume and Maria Sergeyeva
5 minute read | January.27.2025
The Commerce Department issued a rule that increases export controls on AI-related items, among other unprecedented steps. We discuss 3 key takeaways.
by John Coleman, Amanda Lawrence, John (Jay) Williams, Brian Bartholomay and Ronald Williams
11 minute read | July.06.2023
Since 2011, the Consumer Financial Protection Bureau has enforced actions against companies, recovering billions. CIDs demand docs, testimony.